DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,283,449,000 | +1.3% | 16,488,292 | +2.0% | 0.19% | -3.6% |
Q3 2016 | $1,266,601,000 | -19.1% | 16,157,686 | +4.2% | 0.20% | -22.4% |
Q2 2016 | $1,565,881,000 | +5.6% | 15,503,777 | -0.8% | 0.25% | +3.7% |
Q1 2016 | $1,482,326,000 | -1.6% | 15,626,462 | -3.7% | 0.24% | -1.6% |
Q4 2015 | $1,506,382,000 | +14.0% | 16,218,582 | +4.6% | 0.25% | +8.3% |
Q3 2015 | $1,320,874,000 | -2.9% | 15,501,399 | -2.5% | 0.23% | +5.0% |
Q2 2015 | $1,360,689,000 | -0.5% | 15,897,758 | -1.3% | 0.22% | +2.8% |
Q1 2015 | $1,367,439,000 | -6.2% | 16,106,464 | -5.3% | 0.21% | -8.6% |
Q4 2014 | $1,457,170,000 | +11.1% | 17,001,166 | -1.5% | 0.23% | +5.9% |
Q3 2014 | $1,311,771,000 | -0.7% | 17,264,685 | +2.9% | 0.22% | +0.5% |
Q2 2014 | $1,321,384,000 | +9.4% | 16,783,736 | +4.3% | 0.22% | +5.3% |
Q1 2014 | $1,207,383,000 | +1.9% | 16,098,440 | +4.9% | 0.21% | -0.5% |
Q4 2013 | $1,184,662,000 | +9.4% | 15,345,359 | -1.7% | 0.21% | 0.0% |
Q3 2013 | $1,082,458,000 | +9.9% | 15,615,373 | +0.4% | 0.21% | +5.0% |
Q2 2013 | $984,528,000 | – | 15,553,370 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |